arrow
O

Olamide Animasahun

university of michigan
H指数:10
被引数:732

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oral nano-delivery of a gut microbial metabolite enhances T cell stemness for cancer immunotherapy

口服纳米递送肠道微生物代谢物可增强T细胞干性以用于癌症免疫治疗

2026-08-100
OA
ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression
Nature
IF48.5
2026-02-012
PRE
PNPLA3-I148M genetic variant rewires lipid metabolism to drive programmed cell death in human hepatocytes

PNPLA3-I148M基因变异重编程脂质代谢,驱动人肝细胞程序性死亡。

2025-12-081
OA
Interplay between malic enzyme 2, de novo serine synthesis, and the malate-aspartate shuttle drives metabolic adaptation in triple-negative breast cancer

苹果酸酶2、从头丝氨酸合成与苹果酸-天冬氨酸穿梭之间的相互作用驱动三阴性乳腺癌的代谢适应性

2025-10-150
OAAI
eIF4E Enriched Extracellular Vesicles Induce Immunosuppressive Macrophages through HMGCR-Mediated Metabolic Rewiring

eIF4E富集的外泌体通过HMGCR介导的代谢重编程诱导免疫抑制性巨噬细胞

2025-08-180
OA
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis

异柠檬酸脱氢酶1为组3型髓母细胞瘤的铜死亡做准备

2025-05-150
PRE
Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variant

基于人类诱导多能干细胞的脂质代谢相关TM6SF2-E167K变体的肝脏建模

2024-08-270
OAAI
Inulin-gel-based oral immunotherapy remodels the small intestinal microbiome and suppresses food allergy

基于菊粉凝胶的口服免疫疗法可重塑小肠微生物组并抑制食物过敏

2024-07-083
PRE
ISOCITRATE DEHYDROGENASE 1 INHIBITION PRIMES GROUP-3 MEDULLOBLASTOMAS FOR CUPROPTOSIS
2024-06-180
OAAI
Porous PDMS-Based Microsystem (ExoSponge) for Rapid Cost-Effective Tumor Extracellular Vesicle Isolation and Mass Spectrometry-Based Metabolic Biomarker Screening

基于多孔PDMS的微系统 (ExoSponge) 用于快速经济有效的肿瘤细胞外囊泡隔离和基于质谱的代谢生物标志物筛选

2023-01-294
PRE
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer
2022-09-2118
PRE